Production (Stage)
GenSight Biologics S.A.
GSGTF
$0.24
-$0.08-25.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.04% | -61.20% | |||
| Total Other Revenue | -3.01% | -22.90% | |||
| Total Revenue | -3.04% | -46.98% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -3.04% | -46.98% | |||
| SG&A Expenses | -3.04% | 15.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.04% | 4.12% | |||
| Operating Income | 3.04% | -16.05% | |||
| Income Before Tax | 3.04% | -42.24% | |||
| Income Tax Expenses | -3.41% | 225.93% | |||
| Earnings from Continuing Operations | 3.04% | -42.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.04% | -42.40% | |||
| EBIT | 3.04% | -16.05% | |||
| EBITDA | 3.04% | -15.64% | |||
| EPS Basic | 2.91% | -8.42% | |||
| Normalized Basic EPS | 3.11% | -8.44% | |||
| EPS Diluted | 2.91% | -8.42% | |||
| Normalized Diluted EPS | 3.11% | -8.44% | |||
| Average Basic Shares Outstanding | 0.00% | 31.43% | |||
| Average Diluted Shares Outstanding | 0.00% | 31.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||